Journal CME, April 2024: Daily versus three times weekly dosing for treatment of iron deficiency nonanemia in NCAA Division 1 female athletes-Daily versus three times weekly dosing for treatment of iron deficiency nonanemia in NCAA Division 1 female athletes

Daily versus three times weekly dosing for treatment of iron deficiency nonanemia in NCAA Division 1 female athletes

Pdf Summary

The study compared daily versus three times weekly (TIW) oral iron supplementation regimens for treating iron deficiency nonanemia in female NCAA Division 1 athletes. Both regimens increased serum ferritin levels significantly, with the daily regimen showing a larger increase than the TIW regimen. Athletes on the TIW regimen experienced less nausea and constipation compared to the daily regimen. Compliance did not significantly differ between the two groups. The study suggests that iron supplementation with oral ferrous bisglycinate is effective in improving iron levels with minimal side effects. Baseline ferritin levels should be considered when prescribing supplementation regimens. The study was limited by the sample size and the non-randomized design. Future research should include blinding and extended durations to assess compliance more comprehensively. The findings highlight the potential benefits of TIW dosing for iron supplementation in female athletes to improve iron levels and minimize side effects, supporting the use of this regimen in practice.

Asset Caption

Daily versus three times weekly dosing for treatment of iron deficiency nonanemia in NCAA Division 1 female athletes

Keywords

iron deficiency nonanemia

oral iron supplementation

female athletes

NCAA Division 1

serum ferritin levels

oral ferrous bisglycinate

side effects

compliance

supplementation regimens

TIW dosing